Biosimilars
Introduced in the 1980s, biologic medications have since become important tools in modern medicine. However, biologics are expensive, greatly affecting the healthcare budgets of both underdeveloped and developed countries. Fortunately, biosimilars, which are highly similar, reverse-engineered versio...
Saved in:
Other Authors: | Feijó Azevedo, Valderilio (Editor), Moots, Robert (Editor) |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
IntechOpen
2022
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biosimilars in Europe
Published: (2023) -
Drug Repurposing Molecular Aspects and Therapeutic Applications
Published: (2022) -
Vaccine Development
Published: (2022) -
Radiopharmaceuticals Current Research for Better Diagnosis and Therapy
Published: (2022) -
High-Throughput Screening for Drug Discovery
Published: (2022)